US Broker Ratings

AtriCure, Inc. (ATRC) Stock Analysis: Exploring a Potential 59.63% Upside as Analysts Stay Bullish

AtriCure, Inc. (NASDAQ: ATRC) stands at a compelling juncture for investors seeking opportunities in the healthcare sector. This Ohio-based company, specializing in medical instruments and supplies,..

Amphastar Pharmaceuticals, Inc. (AMPH) Stock Analysis: Potential Upside of 38% Attracts Investor Attention

Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH), a biopharmaceutical company specializing in the development, manufacture, and sale of generic and proprietary injectable, inhalation, and intranasal products, presents a..

The Pennant Group, Inc. (PNTG): Investor Outlook Reveals 11.87% Potential Upside

The Pennant Group, Inc. (NASDAQ: PNTG), a notable player in the healthcare sector, specifically within the medical care facilities industry, has recently captured investor attention with..

agilon health, inc. (AGL) Investor Outlook: Assessing a 54.75% Potential Upside Amidst Challenging Metrics

As agilon health, inc. (NYSE: AGL) continues to navigate the complexities of the healthcare sector, individual investors are drawn to the intriguing potential upside of 54.75%..

10x Genomics, Inc. (TXG) Stock Analysis: A Closer Look at the Healthcare Innovator’s Growth Potential and Analyst Ratings

10x Genomics, Inc. (NASDAQ: TXG), a leading player in the healthcare sector, particularly in health information services, is making waves with its innovative solutions for biological..

Alphatec Holdings, Inc. (ATEC) Stock Analysis: Unveiling an 82.74% Upside Potential in the Medical Device Sector

For investors seeking opportunities in the dynamic healthcare sector, Alphatec Holdings, Inc. (NASDAQ: ATEC) presents a compelling case with its significant potential upside. Specializing in the..

Pediatrix Medical Group, Inc. (MD) Stock Analysis: Exploring a 9% Potential Upside in the Healthcare Sector

Investors looking at the healthcare sector might find Pediatrix Medical Group, Inc. (MD) an intriguing prospect. With a market capitalization of $1.68 billion, this U.S.-based company..

Healthcare Services Group, Inc. (HCSG) Stock Analysis: Exploring an 8% Potential Upside with Solid Growth Indicators

Healthcare Services Group, Inc. (NASDAQ: HCSG) is a compelling player in the healthcare sector, specializing in essential management and operational services for medical care facilities. Headquartered..

MannKind Corporation (MNKD): Investor Outlook on a Biotech Player with 154% Potential Upside

MannKind Corporation (NASDAQ: MNKD), a prominent player in the biotechnology sector, is capturing the attention of investors with its compelling growth narrative and significant potential upside...

BGM Group Ltd. (BGM): Navigating Volatility in the Chinese Healthcare Sector

BGM Group Ltd. (BGM), a notable player in China’s healthcare sector, operates within the niche segment of specialty and generic drug manufacturing. With its market capitalization..

Establishment Labs Holdings Inc (ESTA)

⚠️ No article content returned.

..

Opko Health, Inc. (OPK) Stock Analysis: Exploring a 174% Potential Upside Amidst Challenging Fundamentals

Opko Health, Inc. (NASDAQ: OPK), a Miami-based healthcare company, is currently trading at $1.24 with a market capitalization of approximately $984.29 million. Despite its modest stock..

Wave Life Sciences Ltd. (WVE) Stock Analysis: Biotechnology Innovator with 140% Upside Potential

Wave Life Sciences Ltd. (NASDAQ: WVE) is turning heads in the biotechnology sector with its cutting-edge approach to RNA medicine. Founded in 2012 and based in..

Recursion Pharmaceuticals, Inc. (RXRX) Stock Analysis: Uncovering a Potential 84.97% Upside in Biotech

Recursion Pharmaceuticals, Inc. (NASDAQ: RXRX) is making waves in the biotechnology sector, leveraging its innovative approach to drug discovery. The company’s focus on integrating biology, chemistry,..

Supernus Pharmaceuticals (SUPN) Stock Analysis: A 14.66% Upside and Strong Buy Ratings Shape Investor Outlook

Supernus Pharmaceuticals, Inc. (NASDAQ: SUPN) offers investors a compelling prospect with a reported potential upside of 14.66%. As a specialty and generic drug manufacturer in the..

Mesoblast Limited (MESO) Investor Outlook: Exploring a 141% Potential Upside in Biotech

Mesoblast Limited (MESO), a pioneering biotechnology firm in the healthcare sector, presents a compelling opportunity for investors, especially with an impressive potential upside of 141.21% implied..

Tandem Diabetes Care, Inc. (TNDM) Stock Analysis: Evaluating the 17% Potential Upside for Healthcare Investors

Tandem Diabetes Care, Inc. (NASDAQ: TNDM) stands out in the healthcare sector with its innovative approach to diabetes management. As a leading player in the medical..

Phreesia, Inc. (PHR) Stock Analysis: Exploring a Potential 128% Upside in Healthcare SaaS

Phreesia, Inc. (PHR), a Wilmington, Delaware-based company, is making waves with its innovative SaaS-based software and payment platform tailored for the healthcare industry. Despite a challenging..

MoonLake Immunotherapeutics (MLTX) Stock Analysis: Exploring a 34.94% Upside in the Biotech Sphere

MoonLake Immunotherapeutics (NASDAQ: MLTX), a Switzerland-based clinical-stage biotechnology firm, is capturing the attention of investors with a potential upside of 34.94%, according to analyst estimates. Specializing..

Evolent Health, Inc (EVH) Stock Analysis: Exploring a 44.65% Potential Upside in Health Information Services

Evolent Health, Inc (NASDAQ: EVH), a prominent player in the health information services sector, offers a unique proposition for investors seeking exposure to the burgeoning healthcare..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds